| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.48 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |